InvestorsHub Logo
Followers 165
Posts 13286
Boards Moderated 0
Alias Born 03/06/2011

Re: Jumpinjackas post# 14744

Tuesday, 09/20/2016 9:01:15 AM

Tuesday, September 20, 2016 9:01:15 AM

Post# of 16750
Nice premium being paid for this small bio-tech. Could clsn start to get re-priced ?

Allergan Buys Tobira for Up to $1.7 Billion to Gain Liver Drug
[Bloomberg]
Doni Bloomfield
September 20, 2016

Allergan Plc agreed to buy Tobira Therapeutics Inc. for as much as $1.7 billion to gain a late-stage experimental drug to treat liver diseases, one of the most anticipated categories in biotechnology.

All my posts are my OPINION>>IMO>>>Do your own Due Diligence!!.......rareF...deal with it